eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

How to?

Review: could Livedo reticularis cause Petechiae?

We study 2 people who have Livedo reticularis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

Petechiae

Petechiae (a small red or purple spot caused by bleeding into the skin) (latest reports from 35,046 patients) has been reported by people with idiopathic thrombocytopenic purpura, high blood pressure, rheumatoid arthritis, depression, multiple myeloma.

On Aug, 19, 2014: No report is found.

You can also:

Get connected! Join a mobile support group to help out with your experience or learn from others anytime and anywhere:
- group for people who have Petechiae

Common treatments for Livedo Reticularis and their efficacy:

Could your drug cause it?

Comments from related studies:

  • From this study (5 days ago):

  • Red spots, to flamish and one blemmish on inside of elbow appeard suddenly during the day

    Reply

Post a new comment    OR    Read more comments

Can you answer these questions (what is this?):

More questions for: Livedo reticularis, Petechiae

You may be interested at these reviews (what is this?):

  • Petechiae after taking plant sterols
    after taking plant sterols for five years i switched brands,withinn a few days i developed minute petechiae on my lower legs and especially behind my knees and inner thighs. My legs were also swelling and feeling tight. i stopped taking the sterols and after a week the petechiae disappeared along w ...

More reviews for: Livedo reticularis, Petechiae

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

40 million health professionals and patients have studied on eHealthMe. Recent studies:

- Loratadine for a 69-year old man who has Allergies (40 minutes ago)

- Inderal LA for a 75-year old man who has Tremor - Ess ... (1 hour ago)

- Amitriptyline Hydrochloride, Olanzapine, Naproxen for ... (2 hours ago)

Related condition

- Idiopathic or primary livedo reticularis (0 reports)

 

Related symptom

- Petechiae

 

 

Recent user comments

- "Switched time of dosage from night until morning. Fat ... " (47 seconds ago)

- "I took this for six days and then on the sixth day I ... " (40 minutes ago)

- "There is a thick white discharge with itching and an ... " (7 hours ago)

 

Recent mobile support groups

- Short-Term Memory Loss and Cymbalta

- Vistaril and Adderall

- Saccharomyces Boulardii and Cellulitis

- Testim

- Testosterone

 

Popular searches

- Tennis Shoulder
- Korean Red Ginseng
- Vitamin B12
- Psoriatic Arthropathy
- Mirena

   

Drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Side effects: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Symptoms: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.